This test has been discontinued.
It is recommended as an alternative to test the C3 and C4 levels which are reduced in immune complex disease. The C5b-9 assay can as well be used as a marker of complement activation.
For further information:
The Immunopathology team can be reached via email: immunology@adhb.govt.nz or via Lablink (09) 307 4949 EXT 22000
Last updated: 30/04/2026